Sunshine Biopharma Inc.: Form 8-K, filed Apr 28, 2014
Filed with the SEC on Apr 28, 2014 and accepted by EDGAR at Apr 28, 2014, 16:34 ET.
Items reported
- Item 1.01 Entry into a material agreement
- Item 7.01 Regulation FD disclosure
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001354488-14-002090. Last ingested by Listed: Nov 14, 2026, 19:46 ET. Listed shows no prices and gives no investment advice.